November 05, 2019
Rose
Manufacturers say the current shortage is among the worst they have experienced since the popular, wide-ranging treatment came to market. In other pharmaceutical news: Sen. Bill Cassidy (R-La.) touts value-based payments for cutting drug costs; a new approach to gene therapy offers tentative hope; a controversy arises over a pre-term birth medication; and more.
from Kaiser Health News https://ift.tt/2oORPx3
November 05, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: February 6, 2018- States Forced To Ensure ACA Plans Have Enough In-Network Physicians To Make Them Usable
- As Stock Market Slides, Health Systems And Insurers Are Pulled Along
- What Might Be Next After Medicaid Work Mandates? Lifetime Limits On Adults Access To Coverage
- Bipartisan ‘Right-To-Try’ Bill Would Keep FDA In The Loop Which May Ease Pharma Worries
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment